Skip to content

IBC-Research with Hazardous Materials

All research conducted by Texas A&M University-Commerce employees or students, involving any of the agents/materials listed below, must be approved by the Texas A&M University-Commerce Institutional Biosafety Committee (IBC) prior to initiation of the research:

  • Pathogens and potential pathogens of humans, animals or plants;
  • Materials potentially containing human pathogens (including human blood, tissue, and cell lines; non-human primate blood, tissue, and cell lines);
  • Recombinant DNA (and RNA) including creation or use of transgenic plants and animals;
  • Select agents and toxins (see including strains and amounts exempted from the select agent regulations;
  • Any material requiring a Center for Disease Control import license or a United States Department of Agriculture permit.

Biosafety Required Training

All individuals involved in the biosafety research must first complete the required compliance training, Biosafety and Responsible Conduct in Research. This requirement is met by the successful completion of the online training module from the Collaborative Institutional Training Initiative (CITI) website.

Steps to Register and Begin Your Training:

CITI Website Link:

Click "New Users Register Here"
Select Texas A&M University-Commerce as your participating institution
Complete the remaining registration form
Select the Biosafety/Biosecurity Course in the Learner Groups:

  • Biosafety Complete Training Series Groups

You are also required to complete the Responsible Conduct of Research module.  Please select the appropriate module from the following:

  • Biomedical Responsible Conduct of Research Course
  • Social and Behavioral Responsible Conduct of Research Course
  • Physical Science Responsible Conduct of Research Course
  • Humanities Responsible Conduct of Research Course

Actual Course Titles are as listed above.

Standard Operating Procedures

Biosafety Protocol Forms

To gain approval of your biosafety research you must complete and submit the appropriate biosafety protocol forms.

Required Protocol Forms

Additional Protocol Forms (if applicable)

Please submit your protocols to Ms. Glenda Denton, Office of Sponsored Programs or

2022 Fall IBC Meeting Schedule

Time: 1:00 p.m. - 2:00 p.m.
Place: NHS 329 or via Zoom

The public is welcome to attend all IBC meetings as listed in the schedule below.

All IBC submissions (new protocols, renewals or amendments) MAY require full board review and must be reviewed at convened meetings of the IBC. To ensure adequate time for review and consideration, submissions should be sent to by the deadlines indicated below. Prescreening by the IBC staff may identify revisions required by the investigator. These revisions could delay full board review, so all investigators and others are asked to please plan accordingly and submit early.

IBC Submission Dates for IBC Review

IBC Meeting Dates

Tuesday, July 12, 2022

Tuesday, August 9, 2022

Tuesday, August 16, 2022

Tuesday, September 13, 2022

Tuesday, September 13, 2022

Tuesday, October 11, 2022

Tuesday, October 11, 2022

Tuesday, November 8, 2022

Tuesday, November 15, 2022

Tuesday, December 13, 2022


Please contact Dr. Venu Cheriyath, IBC Chair (903-468-3116) or or Ms. Glenda Denton (903-886-5766) or